Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.

about

Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.Automated One-pot Radiosynthesis of [11C]S-adenosyl Methionine.

P2860

Q38932290-84C2294D-4D09-424F-AE54-A6C3D8DC3C26 Q47134848-61A5A037-55D9-4BA8-9AB4-54D4701B85BB

P2860

Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.

Item

http://www.wikidata.org/entity/Q38838285

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Molecular imaging to guide sys ...... PET imaging cancer biomarkers.

@en

type

Item

label

Molecular imaging to guide sys ...... PET imaging cancer biomarkers.

@en

prefLabel

Molecular imaging to guide sys ...... PET imaging cancer biomarkers.

@en

P1476

Molecular imaging to guide sys ...... PET imaging cancer biomarkers.

@en

P2093

Austin R Pantel

http://www.w3.org/2001/XMLSchema#string

David A Mankoff

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status

Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics

Glutamine and cancer: cell biology, physiology, and clinical opportunities

Q27021937

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

P304

25-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.CANLET.2016.05.008

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

387

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27195912

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5839329

http://www.w3.org/2001/XMLSchema#string

Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.

about

P2860

P2860

Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932